tiprankstipranks
Trending News
More News >
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market

Pyxis Oncology (PYXS) Income Statement

Compare
598 Followers

Pyxis Oncology Income Statement

Last quarter (Q4 2025), Pyxis Oncology's total revenue was $11.04M, an increase of Infinity% from the same quarter last year. In Q4, Pyxis Oncology's net income was $-18.11M. See Pyxis Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 13.86M$ 16.15M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 11.47M$ 15.67M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 95.89M$ 105.13M$ 82.20M$ 123.48M$ 69.72M
Depreciation and Amortization
$ 0.00$ 2.98M$ 1.93M$ 709.00K$ 647.00K
EBITDA
$ -84.42M$ -65.51M$ -80.27M$ -122.77M$ -69.07M
Operating Income
$ -84.42M$ -89.46M$ -82.20M$ -123.48M$ -69.72M
Other Income/Expenses
$ 6.18M$ 9.96M$ 8.41M$ 2.76M$ -6.26M
Pretax Income
$ -78.23M$ -79.50M$ -73.79M$ -120.72M$ -75.97M
Net Income
$ -79.62M$ -77.33M$ -73.79M$ -120.72M$ -75.97M
Per Share Metrics
Basic EPS
$ -1.28$ -1.32$ -1.85$ -3.57$ -2.53
Diluted EPS
$ -1.28$ -1.32$ -1.85$ -3.57$ -2.53
Weighted Average Shares Outstanding
62.14M 58.45M 39.90M 33.03M 32.22M
Weighted Average Shares Outstanding (Diluted)
62.14M 58.45M 39.90M 33.03M 32.22M
Currency in USD

Pyxis Oncology Earnings and Revenue History